A technology developed at Vanderbilt University Medical Center has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant.
Click here for original story, ‘Ultra-potent’ antibody against COVID-19 variants
Source: Phys.org